Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Part of paid clinical trials in St Louis, Missouri.

Sponsor
Washington University School of Medicine
Study ID
NCT05582551
Status
Recruiting
Apply to this trial

Conditions

  • Childhood Cancer

Eligibility Criteria

Sex
ALL
Age
7 Years - 17 Years
Healthy Volunteers
Not accepted

Interventions

  • Highlighting Patients at Risk for Sensory Screening (HPARSS) — OTHER
    Collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the HPARSS document.

Study Details

The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS). Using a cross sectional design study, collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the highlighting patients at risk for sensory screening (HPARSS) document. The investigators will utilize the HPARSS that will link therapy related risks for sensory deficits to specific screening procedures prompting the primary oncology provider to implement screening, diagnostic testing, and therapy.

Key Dates

Start date
Aug 2, 2023
Status verified
Dec 2025
Primary completion
May 31, 2026
Completion
May 31, 2026

Study Design

Enrollment
146 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Patients: Highlighting Patients at Risk for Sensory Screening (HPARSS)
    * The primary oncology team will utilize the HPARSS to identify patients who are at risk for sensory deficits based on prior treatment. The HPARSS will constitute a file of that will contain eligible patients based upon their past treatment and their corresponding risk for a particular sensory deficit based upon that treatment. The patient and parent/guardian will be approached to participate in the study. * Sensory deficit screening will be completed in the clinic and any screening results that indicate the need for referral for diagnostic testing or therapy will be scheduled by the primary treatment team staff.
  • No Intervention: Providers: Highlighting Patients at Risk for Sensory Screening (HPARSS)
    -Providers will complete a survey regarding their views of the HPARSS. The Acceptability of Intervention Measure has 4 questions and the Feasibility of Intervention Measure has 4 questions.

Primary Outcome Measure

Percentage of patients with at risk for sensory deficits identified by HPARSS [ Time Frame: Through completion of enrollment for all patients (estimated to be 9 months) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
St. Louis Children's Hospital - Washington University School of MedicineSt LouisMissouri63110
Robert J Hayashi, M.D.
[email protected]
314-454-6018
Robert J Hayashi, M.D. (PRINCIPAL_INVESTIGATOR)
Ashley Housten, OTD, MSCI (SUB_INVESTIGATOR)
Thomas Kannampallil, Ph.D. (SUB_INVESTIGATOR)
Patrick Lyons, M.D., MSc (SUB_INVESTIGATOR)
Susan Hayashi, MA (SUB_INVESTIGATOR)
Belinda Sinks, AUD (SUB_INVESTIGATOR)
Anna Perlmutter, OTR/L (SUB_INVESTIGATOR)
Feng Gao, M.D., Ph.D., MPH, MS (SUB_INVESTIGATOR)

Find similar trials in St Louis, MO

By research site
St. Louis Children's Hospital - Washington University School of Medicine· St Louis, MO

Related Studies